BridgeMD
New treatment option for Breast Cancer With Low to Intermediate HER2 Expression
Official title Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer
ClinicalTrials.gov ID: NCT07630402
What this study is testing
- What it's testing
- The purpose of this study is to determine whether a personalized, risk-stratified surveillance strategy can safely reduce unnecessary cardiac imaging while preserving early detection of treatment-related cardiotoxicity in women with breast cancer (BC) receiving HER2-targeted therapy (HER2-TT).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 79, women only
You may be able to join if
- Female sex, age 18-79 years.
- Histologically confirmed HER2-positive BC scheduled for ≈12 months of adjuvant HER2-TT
- Baseline LVEF ≥ 55 % by 2-D echocardiography.
- Ability to provide informed consent.
You likely can't join if
- Prior HF, myocardial infarction, or cardiomyopathy.
- Atrial fibrillation or significant valvular heart disease.
- Cumulative anthracycline dose ≥ 250 mg/m².
- Pregnancy or lactation.
- Inability to comply with study procedures.
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 79 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.